AstraZeneca Pharma India announces a change in its leadership with the appointment of Dr. Sanjeev Panchal as Country President & Managing Director, AstraZeneca Pharma India Ltd with effect from 1st January 2023.

Sanjeev has been with AstraZeneca for 19 years and began his career in India back in 2003 as a Brand Associate. Over time, he progressed through several positions in India, Indonesia, Asia Pacific and International region, based in Singapore and the UK.

Sanjeev is currently the Country President for AstraZeneca Malaysia, where he has been instrumental in transforming the business, by driving new launches, innovative patient centric partnerships and Market Access strategies, guiding an inclusive and diverse team to achieve double digit growth outpacing market. He played a critical role in supporting the government in combating the pandemic through AstraZeneca’s Covid-19 vaccine and long-acting monoclonal antibodies, as well as leading the Corporate Affairs strategy and sustainability initiatives.

Commenting on his appointment, Dr Sanjeev Panchal said, “AstraZeneca’s bold ambition is to be pioneers in science and transform patient outcomes by delivering a robust pipeline of new medicines and leading in sustainability. Expansion, innovation, and patient centric partnership are at the heart of how we make health happen, supported by the diversity of our organisation and driven by our shared goal. I am delighted to return to India and take on the journey that Gagandeep Singh has established for the country, and I am really looking forward to collaborating with the team as we continue to push the boundaries of science to make health happen for people, society and planet”.